19
Nov
Shilpa Medicare shares rose over 6 per cent in early trade on November 19, after it announced that its subsidiary Shilpa Pharma Lifesciences has received two Certificates of Suitability (CEPs) from the European Directorate for Medicines and Healthcare Quality (EDQM).At 1.15 pm, Shilpa Medicare shares were trading over 3 per cent higher at Rs 892. The stock has rallied a massive 180 per cent on a year-to-date basis, outperforming the Nifty 50 by a huge margin, which gained 9 per cent during the same time period.The first CEP received on November 18 was for Octreotide The second CEP approval received…